Efficient methods to functionalize proteins are essential for the development of many diagnostic and therapeutic compounds, such as fluorescent probes for immunohistochemistry, zirconium-89 radiolabeled mAbs (89Zr-mAbs) for positron emission tomography and antibody-drug conjugates (ADCs). This protocol describes a step-by-step procedure for the light-induced functionalization of proteins with compounds bearing the photochemically active aryl azide group. As an illustration of the potential utility of our approach, this protocol focuses on the synthesis of 89Zr-mAbs using photoactivatable derivatives of the metal ion binding chelate desferrioxamine B (DFO). The light-induced synthesis of 89Zr-mAbs is a unique, one-pot process involving simultaneous radiolabeling and protein conjugation. The photoradiochemical synthesis of purified 89Zr-mAbs, starting from unmodified proteins, [89Zr][Zr(C2O4)4]4– (89Zr-oxalate), and a photoactivatable DFO derivative, can be performed in <90 min. The method can be easily adapted to prepare other radiolabeled proteins, ADCs or fluorescently tagged proteins by using drug molecules or fluorophores functionalized with photoactive moieties.
This is a preview of subscription content, access via your institution
Open Access articles citing this article.
Automated light-induced synthesis of 89Zr-radiolabeled antibodies for immuno-positron emission tomography
Scientific Reports Open Access 13 January 2022
Access Nature and 54 other Nature Portfolio journals
Get Nature+, our best-value online-access subscription
$29.99 / 30 days
cancel any time
Subscribe to this journal
Receive 12 print issues and online access
$259.00 per year
only $21.58 per issue
Rent or buy this article
Prices vary by article type
Prices may be subject to local taxes which are calculated during checkout
Source data for the analytical chromatography and PET images are available from the corresponding author.
Boros, E. & Holland, J. P. Chemical aspects of metal ion chelation in the synthesis and application antibody-based radiotracers. J. Labelled Comp. Radiopharm 61, 652–671 (2018).
Lang, K. & Chin, J. W. Bioorthogonal reactions for labeling proteins. ACS Chem. Biol. 9, 16–20 (2014).
Spicer, C. D. & Davis, B. G. Selective chemical protein modification. Nat. Commun. 5, 4740 (2014).
Boutureira, O. & Bernardes, G. J. L. Advances in chemical protein modification. Chem. Rev. 115, 2174–2195 (2015).
Krall, N., Da Cruz, F. P., Boutureira, O. & Bernardes, G. J. L. Site-selective protein-modification chemistry for basic biology and drug development. Nat. Chem 8, 103–113 (2016).
Baumann, A. L. & Hackenberger, C. P. R. Modern ligation methods to access natural and modified proteins. Chimia (Aarau) 72, 802–808 (2018).
Adumeau, P., Sharma, S. K., Brent, C. & Zeglis, B. M. Site-specifically labeled immunoconjugates for molecular imaging—part 1: cysteine residues and glycans. Mol. Imaging Biol. 18, 1–17 (2016).
Adumeau, P., Sharma, S. K., Brent, C. & Zeglis, B. M. Site-specifically labeled immunoconjugates for molecular imaging—part 2: peptide tags and unnatural amino acids. Mol. Imaging Biol. 18, 153–165 (2016).
Meyer, J. P., Adumeau, P., Lewis, J. S. & Zeglis, B. M. Click chemistry and radiochemistry: the first 10 years. Bioconjug. Chem. 27, 2791–2807 (2016).
Fay, R. & Holland, J. P. The impact of emerging bioconjugation chemistries on radiopharmaceuticals. J. Nucl. Med. 60, 587–591 (2019).
Vosjan, M. J. W. D. et al. Conjugation and radiolabeling of monoclonal antibodies with zirconium-89 for PET imaging using the bifunctional chelate p-isothiocyanatobenzyl-desferrioxamine. Nat. Protoc. 5, 739–743 (2010).
Perk, L. R. et al. p-Isothiocyanatobenzyl-desferrioxamine: a new bifunctional chelate for facile radiolabeling of monoclonal antibodies with zirconium-89 for immuno-PET imaging. Eur. J. Nucl. Med. Mol. Imaging 37, 250–259 (2010).
Patra, M., Eichenberger, L. S., Fischer, G. & Holland, J. P. Photochemical conjugation and one-pot radiolabelling of antibodies for immuno-PET. Angew. Chemie Int. Ed. Engl. 58, 1928–1933 (2019).
Eichenberger, L. S., Patra, M. & Holland, J. P. Photoactive chelates for radiolabelling proteins. Chem. Commun. 55, 2257–2260 (2019).
Patra, M., Klingler, S., Eichenberger, L. S. & Holland, J. Simultaneous photoradiochemical labelling of antibodies for immuno-PET. iScience 13, 416–431 (2019).
Fay, R., Gut, M. & Holland, J. P. Photoradiosynthesis of 68Ga-labeled HBED-CC-azepin-MetMAb for immuno-PET of c-MET receptors. Bioconjug. Chem. 30, 1814–1820 (2019).
Gut, M. & Holland, J. P. Synthesis and photochemical studies on gallium and indium complexes of DTPA-PEG3-ArN3 for radiolabelling antibodies. Inorg. Chem. 58, 12302–12310 (2019).
Klingler, S., Fay, R. & Holland, J. P. Light-induced radiosynthesis of 89ZrDFO-azepin-onartuzumab for imaging the hepatocyte growth factor receptor. J. Nucl. Med. 61, 1072–1078 (2020).
Holland, J. P., Gut, M., Klingler, S., Fay, R. & Guillou, A. Photochemical reactions in the synthesis of protein‐drug conjugates. Chemistry 26, 33–48 (2020).
Guillou, A., Earley, D. F. & Holland, J. P. Light-activated protein-conjugation and 89Zr-radiolabelling with water-soluble desferrioxamine derivatives. Chemistry 26, 7185–7189 (2020).
Fay, R., Linden, A. & Holland, J. P. PhotoTag: photoactivatable fluorophores for protein labeling. Org. Lett. 22, 3499–3503 (2020).
Poot, A. J. et al. Fully automated zirconium-89 labeling and purification of antibodies. J. Nucl. Med. 60, 691–695 (2019).
Liu, P. et al. A bioorthogonal small-molecule-switch system for controlling protein function in live cells. Angew. Chemie Int. Ed. Engl. 53, 10049–10055 (2014).
Xiang, H. et al. Onartuzumab (MetMab): using nonclinical pharmacokinetic and concentration-effect data to support clinical development. Clin. Cancer Res. 19, 5068–5078 (2013).
Zanzonico, P. Routine quality control of clinical nuclear medicine instrumentation: a brief review. J. Nucl. Med. 49, 1114–1131 (2008).
Holland, J. P. Chemical kinetics of radiolabelling reactions. Chemistry 24, 16472–16483 (2018).
Klán, P. & Wirz, J. Photochemistry of Organic Compounds: From Concepts to Practice (Wiley, 2009).
J.P.H. thanks the Swiss National Science Foundation (SNSF Professorship PP00P2_163683 and PP00P2_190093), the Swiss Cancer League (Krebsliga Schweiz; KLS-4257-08-2017) and the University of Zurich (UZH) for financial support. This project has received funding from the European Union’s Horizon 2020 research and innovation programme, from the European Research Council under the Grant Agreement No. 676904, ERC-StG-2015, NanoSCAN. We thank all members of the Radiochemistry and Imaging Science group at UZH for helpful discussions.
The authors declare no competing interests.
Peer review information Nature Protocols thanks David Watt and the other, anonymous, reviewer(s) for their contribution to the peer review of this work.
Publisher’s note Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
Key references using this protocol
Guillou, A., Earley, D. F. & Holland, J. P. Chemistry 26, 7185–7189 (2020): https://chemistry-europe.onlinelibrary.wiley.com/doi/abs/10.1002/chem.202001755
Klingler, S., Fay, R. & Holland, J. P. J. Nucl. Med. (2020): http://jnm.snmjournals.org/content/early/2020/01/09/jnumed.119.237180
Patra, M., Klingler, S., Eichenberger, L. S. & Holland, J. P. iScience 13, 416–431 (2019): https://www.sciencedirect.com/science/article/pii/S2589004219300707
About this article
Cite this article
Guillou, A., Earley, D.F., Patra, M. et al. Light-induced synthesis of protein conjugates and its application in photoradiosynthesis of 89Zr-radiolabeled monoclonal antibodies. Nat Protoc 15, 3579–3594 (2020). https://doi.org/10.1038/s41596-020-0386-5